After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Bristol-Myers Squibb Co is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Bristol-Myers Squibb Co is $92.81B. A total of 16.31 million shares were traded on the day, compared to an average of 14.51M shares.
In the most recent transaction, Elkins David V sold 56,000 shares of BMY for 47.33 per share on Sep 02 ’25. After the transaction, the EVP, Chief Financial Officer now owns 167,379 company shares. In a previous transaction on Sep 02 ’25, Elkins David V bought 56,000 shares at 47.30 per share.
Among the insiders who sold shares, Short Bartie Wendy disposed of 378 shares on Aug 02 ’25 at a per-share price of $44.23. This resulted in the EVP, Corporate Affairs holding 5,066 shares of BMY after the transaction. In another insider transaction, Hickey Benjamin sold 97 shares at $38.01 per share on May 09 ’25. Company shares held by the President, RayzeBio Org. now total 0.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Bristol-Myers Squibb Co pays an annual dividend of $2.48, resulting in a dividend yield of 5.44%, and it has a price to earnings (P/E) ratio of 15.39.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $42.52.
As of this writing, BMY has an earnings estimate of $1.65 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $1.8 per share and a lower estimate of $1.56. The company reported an EPS of $1.67 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $9.11, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.38.
